Neha Krishnamohan - 15 May 2025 Form 4 Insider Report for Artiva Biotherapeutics, Inc. (ARTV)

Role
Chief Financial Officer
Signature
/s/ Neha Krishnamohan
Issuer symbol
ARTV
Transactions as of
15 May 2025
Net transactions value
-$18,842
Form type
4
Filing time
18 Aug 2025, 20:15:10 UTC
Previous filing
28 Feb 2025
Next filing
16 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Krishnamohan Neha Chief Financial Officer C/O ARTIVA BIOTHERAPEUTICS, INC., 5505 MOREHOUSE DRIVE, SUITE 100, SAN DIEGO /s/ Neha Krishnamohan 18 Aug 2025 0001866171

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARTV Common Stock Tax liability $2,856 -1,341 -1.2% $2.13 108,659 15 May 2025 Direct F1
transaction ARTV Common Stock Tax liability $15,986 -5,813 -5.3% $2.75 102,846 15 Aug 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of restricted stock unit awards.